Tentative Program

Conference Programme

Tentative Conference Agenda

Explore the proposed two-day programme developed around the conference Session Tracks and aligned United Nations Sustainable Development Goals.

Conference Format Hybrid Conference In-person and virtual participation
Programme 2 Days 27โ€“28 October 2026
Academic Scope 11 Tracks Conference Session Tracks
Research Scope 20 Areas Call for Papers themes
SDG Alignment 4 SDGs SDGs 3, 4, 9 and 12
Tentative Agenda & Timings

Session timings, sequence, track grouping and allocations are tentative and subject to change. Final timings will be confirmed closer to the conference. All timings follow the local time of the conference location.

Day 01

Opening, Keynote & Technical Sessions

27 OCT 2026 HYBRID
  1. 09:00 AM 09:30 AM

    Registration, Welcome Kit Collection & Virtual Check-in

    Participant arrival, credential verification and virtual lobby access.

    HYBRID
  2. 09:30 AM 09:45 AM

    Networking Tea & Digital Welcome

    Informal networking for on-site and virtual participants.

    HYBRID
  3. 09:45 AM 10:30 AM

    Welcome Address, Opening Plenary & Keynote Presentation I

    Opening of the conference and introduction to its research focus.

    PLENARY
  4. 10:30 AM 12:30 PM

    Concurrent Technical Session I

    3 TRACKS
    Track 01
    Advancements in Laboratory Medicine
    39
    Track Overview

    This track focuses on the latest innovations in laboratory medicine, highlighting breakthroughs in diagnostic techniques and methodologies. Participants will explore the integration of technology in enhancing lab efficiency and accuracy.

    Track 02
    Pharmaceutical Chemistry and Drug Development
    39
    Track Overview

    This session will delve into the intricate processes of pharmaceutical chemistry, emphasizing the design and development of novel therapeutic agents. Discussions will include the challenges and advancements in drug formulation and delivery systems.

    Track 03
    Clinical Pharmacy Practices and Patient Care
    34
    Track Overview

    This track aims to examine the role of clinical pharmacy in optimizing patient outcomes through effective medication management. Participants will share insights on collaborative practices between pharmacists and healthcare providers.

  5. 12:30 PM 01:30 PM

    Lunch & Networking Break

    Refreshment interval and networking opportunity.

    BREAK
  6. 01:30 PM 03:30 PM

    Concurrent Technical Session II

    3 TRACKS
    Track 04
    Analytical Techniques in Pharmaceutical Research
    39
    Track Overview

    This session will cover cutting-edge analytical techniques utilized in pharmaceutical research, including chromatography, spectroscopy, and mass spectrometry. Emphasis will be placed on their applications in quality control and drug analysis.

    Track 05
    Translational Research in Pharmacy
    34
    Track Overview

    This track will focus on the translation of laboratory findings into clinical applications, bridging the gap between research and practice. Participants will discuss strategies for enhancing the impact of research on patient care.

    Track 06
    Innovations in Lab Diagnostics
    39
    Track Overview

    This session will highlight recent advancements in laboratory diagnostics, including the development of rapid testing methods and point-of-care technologies. The impact of these innovations on disease management and patient outcomes will be explored.

  7. 03:30 PM 04:00 PM

    Interactive Q&A, Day 1 Summary & Group Photo

    Closing interaction and key takeaways from the first day.

    CLOSING
Day 02

Keynote, Technical Sessions & Awards

28 OCT 2026 HYBRID
  1. 09:00 AM 09:15 AM

    Participant Check-in & Day 2 Welcome

    On-site attendance confirmation and virtual lobby access.

    HYBRID
  2. 09:15 AM 10:00 AM

    Keynote Presentation II

    Expert address on the future of the conference research domain.

    PLENARY
  3. 10:00 AM 12:00 PM

    Concurrent Technical Session III

    3 TRACKS
    Track 07
    Quality Control in Pharmaceutical Manufacturing
    39
    Track Overview

    This track will address the critical aspects of quality control in pharmaceutical manufacturing processes. Discussions will focus on regulatory standards, best practices, and the role of quality assurance in ensuring drug safety.

    Track 08
    Sustainable Practices in Pharmacy
    312
    Track Overview

    This session will explore sustainable practices within the pharmacy sector, emphasizing eco-friendly approaches to drug development and distribution. Participants will discuss the importance of sustainability in enhancing public health outcomes.

    Track 09
    Pharmaceutical Technology Trends
    39
    Track Overview

    This track will examine emerging trends in pharmaceutical technology, including digital health solutions and automation in drug manufacturing. The implications of these trends for the future of pharmacy practice will be critically analyzed.

  4. 12:00 PM 01:00 PM

    Lunch & Networking Break

    Refreshment interval and professional networking.

    BREAK
  5. 01:00 PM 03:00 PM

    Concurrent Technical Session IV

    2 TRACKS
    Track 10
    Educational Strategies in Laboratory Medicine
    49
    Track Overview

    This session will focus on innovative educational strategies for training professionals in laboratory medicine. Participants will share successful models and curricula that enhance learning and competency in lab practices.

    Track 11
    Drug Safety and Pharmacovigilance
    39
    Track Overview

    This track will address the importance of drug safety monitoring and pharmacovigilance in the pharmaceutical industry. Discussions will include methodologies for assessing drug safety and the role of regulatory agencies in protecting public health.

  6. 03:00 PM 03:30 PM

    Publications, Best Paper & Best Presentation Awards

    Publication guidance and recognition of outstanding research contributions.

    AWARDS
  7. 03:30 PM 04:00 PM

    Valedictory Session, Closing Remarks & Group Photo

    Conference summary, acknowledgements and formal conclusion.

    CLOSING
Aligned SDGs
3 Good Health and Well-being 4 Quality Education 9 Industry, Innovation and Infrastructure 12 Responsible Consumption and Production

Be Part of ICPCLMR-26

Submit your research or complete your conference registration.